Stephen T. Schlachter

Author

W.E. Upjohn Institute for Employment Research

Also Known As

S T Schlachter, S. T. SCHLACHTER, Schlachter Stefan, Stephen Schlachter, Stephen T Schlachter, Stephen T. Schlachter

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

W.E. Upjohn Institute for Employment Research Array BioPharma (United States)

About

Stephen T. Schlachter is an author at W.E. Upjohn Institute for Employment Research specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	474
2	Natural Sciences	5	5	201
3	Biochemistry	4	4	134
4	Engineering	1	1	32
5	Health Sciences	1	1	29

Stephen T. Schlachter

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma Eli M. Wallace, James P. Rizzi, Guangzhou Han, Cancer Research	2016	310
Discovery and Preclinical Pharmacology of a Selective ATP-Competitive Akt Inhibitor (GDC-0068) for the Treatment of Human Tumors James F. Blake, Rui Xu, Josef R. Bencsik, Journal of Medicinal Chemistry Human TumorsTumor BiologyMedicinal ChemistryProtein Kinase B/aktDownstream Biomarkers	2012	184
Pyrazoline bisphosphonate esters as novel antiinflammatory and antiarthritic agents Richard A. Nugent, Megan Murphy, Stephen T. Schlachter, Journal of Medicinal Chemistry	1993	116
Design and Activity of Specific Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitors for the Treatment of Clear Cell Renal Cell Carcinoma: Discovery of Clinical Candidate (<i>S</i>)-3-((2,2-Difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1<i>H</i>-inden-4-yl)oxy)-5-fluorobenzonitrile (PT2385) Paul M. Wehn, James P. Rizzi, Darryl D. Dixon, Journal of Medicinal Chemistry	2018	108
DNA-dependent protein kinase inhibitors as drug candidates for the treatment of cancer. Adam Kashishian, Heather Douangpanya, Darcey Clark, PubMed Tumor BiologyGenome InstabilityOncologyDrug CandidatesChemoprevention Strategy	2003	92
Pyrimidine Thioethers: A Novel Class of HIV-1 Reverse Transcriptase Inhibitors with Activity Against BHAP-Resistant HIV Richard A. Nugent, Stephen T. Schlachter, Michael J. Murphy, Journal of Medicinal Chemistry Medicinal ChemistryMedicineNatural SciencesAntiviral Drug DevelopmentAntiviral Therapy	1998	67
Demonstration of novel anti-arthritic and anti-inflammatory effects of diphosphonates. C. J. Dunn, Louise A. Galinet, Hongmei Wu, Journal of Pharmacology and Experimental Therapeutics	1993	63
(−)-6-Chloro-2-[(1-furo[2,3-<i>c</i>]pyridin-5-ylethyl)thio]-4-pyrimidinamine, PNU-142721, a New Broad Spectrum HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor Donn G. Wishka, David R. Graber, Laurice A. Kopta, Journal of Medicinal Chemistry ImmunodeficienciesImmunologyAltmetric Attention ScoreMolecular BiologyMichigan 49001	1998	48
Insight into the unusual reactions of stabilized phosphorus ylides with lactols. A specific intramolecular hydroxyl group effect leads to high z-selectivity. Thomas H. Webb, Lisa M. Thomasco, Stephen T. Schlachter, Tetrahedron Letters EngineeringBiochemistryHigh Z-selectivityUnusual ReactionsNatural Sciences	1988	32
Modulating fast skeletal muscle contraction protects skeletal muscle in animal models of Duchenne muscular dystrophy Alan J. Russell, Mike Duvall, Ben Barthel, Journal of Clinical Investigation Muscle FunctionCytoskeletonMechanotransductionCellular PhysiologyMuscle Physiology	2023	29

Page 1